Paradigm Shift in the Treatment of Patients With ACS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 250 participants.
Also called NCT02041650
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 250 participants
- Registry
-
NCT02041650
-
- Other papers using this trial's data
- High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02041650. Non-randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paradigm Shift in the Treatment of Patients With ACS
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- Yu Bo
- Collaborator
- Massachusetts General Hospital
Record details
- Record id
cardio:ct-nct02041650- Content hash
d19c995ad346bc79e7e782294d34d33068f73210268ffe468ebb4b756b0dbe18